Patent · US Expired

Indole, indazole and indoline derivatives as CETP inhibitors

US7259183B2 · kind B2 · utility

2Cited by

0References

5Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Aurelia Conte-Mayweg · Soest, DE
Holger Kuehne · Soest, DE
Thomas Luebbers · Soest, DE
Cyrille Maugeais · Mulhouse, FR
Werner Mueller · Cologne, DE
Philippe Pflieger · Schwoben, FR

Key dates

Filing date	Aug 4, 2005
Grant date	Aug 21, 2007
Priority date	—
Expiry date	Nov 10, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I):wherein —X—Y—, R1 to R11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.